Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Insight Molecular Diagnostics Inc. IMDX

Full chart Compare
Set alert

Price alert · IMDX

All alert types
2.65 USD -0.09 (-3.28%)

At closeNov 4, 2026, 4:00 PM EST

2.65 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

2.58 Day range 2.99
2.42 52-week range 8.51
YTD
-64.67%
1 year
-56.77%

Financial health

Altman Z-Score

-23.80 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -4.5×
FY 2016: -16.7×FY 2017: -7.2×FY 2018: -3.3×FY 2019: -5.2×FY 2020: -5.2×FY 2021: -3.0×FY 2022: -0.3×FY 2023: -0.7×FY 2024: -0.5×FY 2025: -4.5×
FY 2016 5y median -0.7× FY 2025
P/S 56.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 129×FY 2021: 87.8×FY 2022: 37.1×FY 2023: 12.7×FY 2024: 16.5×FY 2025: 56.4×
FY 2016 5y median 37.1× FY 2025
P/B -7.3×
FY 2016: 19.0×FY 2017: 31.9×FY 2018: 15.3×FY 2019: 3.7×FY 2020: 4.7×FY 2021: 3.0×FY 2022: 0.9×FY 2023: 0.9×FY 2024: -2.5×FY 2025: -7.3×
FY 2016 5y median 0.9× FY 2025
P/FCF -9.0×
FY 2016: -24.5×FY 2017: -10.4×FY 2018: -4.5×FY 2019: -5.6×FY 2020: -5.8×FY 2021: -5.1×FY 2022: -0.7×FY 2023: -0.8×FY 2024: -1.5×FY 2025: -9.0×
FY 2016 5y median -1.5× FY 2025
EV/EBITDA -4.6×
FY 2016: -15.9×FY 2017: -7.4×FY 2018: -3.0×FY 2019: -4.5×FY 2020: -5.2×FY 2021: -3.4×FY 2022: -1.4×FY 2023: -0.5×FY 2024: -0.4×FY 2025: -4.6×
FY 2016 5y median -1.4× FY 2025
EV/Sales 54.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 130×FY 2021: 75.4×FY 2022: 20.0×FY 2023: 8.4×FY 2024: 13.9×FY 2025: 54.4×
FY 2016 5y median 20.0× FY 2025
FCF Yield -11.1%
FY 2016: -4.1%FY 2017: -9.6%FY 2018: -22.4%FY 2019: -17.9%FY 2020: -17.4%FY 2021: -19.8%FY 2022: -140.3%FY 2023: -123.4%FY 2024: -68.2%FY 2025: -11.1%
FY 2016 5y median -68.2% FY 2025

Profitability

Gross Margin 4.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -52.5%FY 2021: 64.6%FY 2022: -1.9%FY 2023: 27.5%FY 2024: 39.3%FY 2025: 4.7%
FY 2016 5y median 27.5% FY 2025
Operating Margin -754.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -2443.3%FY 2021: -2444.3%FY 2022: -1878.6%FY 2023: -1672.4%FY 2024: -3245.1%FY 2025: -754.1%
FY 2016 5y median -1878.6% FY 2025
Net Margin -1238.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -2461.5%FY 2021: -2916.2%FY 2022: -7609.8%FY 2023: -1848.4%FY 2024: -3225.0%FY 2025: -1238.5%
FY 2016 5y median -2916.2% FY 2025
ROE 159.6%
FY 2016: -113.2%FY 2017: -440.0%FY 2018: -460.2%FY 2019: -72.4%FY 2020: -89.4%FY 2021: -98.3%FY 2022: -184.1%FY 2023: -135.7%FY 2024: 494.2%FY 2025: 159.6%
FY 2016 5y median -98.3% FY 2025
ROIC -197.4%
FY 2016: -107.4%FY 2017: -260.4%FY 2018: -275.0%FY 2019: -60.1%FY 2020: -57.9%FY 2021: -30.0%FY 2022: -20.3%FY 2023: -36.8%FY 2024: -209.8%FY 2025: -197.4%
FY 2016 5y median -36.8% FY 2025
ROA -195.0%
FY 2016: -77.3%FY 2017: -189.7%FY 2018: -165.5%FY 2019: -56.0%FY 2020: -54.0%FY 2021: -40.2%FY 2022: -72.8%FY 2023: -37.1%FY 2024: -172.9%FY 2025: -195.0%
FY 2016 5y median -72.8% FY 2025

Growth (YoY)

Revenue 115.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 80.8%FY 2022: -56.4%FY 2023: 56.9%FY 2024: 25.1%FY 2025: 115.6%
FY 2016 FY 2025
Operating Income 49.9%
FY 2016: -27.8%FY 2017: -69.2%FY 2018: 19.3%FY 2019: -46.3%FY 2020: -33.6%FY 2021: -80.8%FY 2022: 66.5%FY 2023: -39.7%FY 2024: -142.8%FY 2025: 49.9%
FY 2016 FY 2025
EPS (diluted) 64.6%
FY 2016: -1.2%FY 2017: -52.4%FY 2018: 35.2%FY 2019: -4.7%FY 2020: -4.9%FY 2021: -57.5%FY 2022: -38.9%FY 2023: 81.3%FY 2024: -24.3%FY 2025: 64.6%
FY 2016 FY 2025
Free Cash Flow -19.5%
FY 2016: -61.3%FY 2017: -76.7%FY 2018: 13.3%FY 2019: -76.7%FY 2020: -31.9%FY 2021: -40.4%FY 2022: -30.7%FY 2023: 52.7%FY 2024: 10.1%FY 2025: -19.5%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 3.0×FY 2017: 1.9×FY 2018: 1.6×FY 2019: 5.2×FY 2020: 1.0×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 1.5×FY 2024: 1.6×FY 2025: 1.3×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 1.2×
FY 2016: 3.0×FY 2017: 1.9×FY 2018: 1.6×FY 2019: 5.2×FY 2020: 1.0×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 1.5×FY 2024: 1.6×FY 2025: 1.2×
FY 2016 5y median 1.6× FY 2025
Debt / Equity -0.1×
FY 2016: 0.1×FY 2017: 0.6×FY 2018: 0.5×FY 2019: 0.2×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: -0.3×FY 2025: -0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 0.9×FY 2017: 0.3×FY 2018: 0.4×FY 2019: 0.7×FY 2020: -0.0×FY 2021: 0.6×FY 2022: 1.2×FY 2023: 0.3×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -281×
FY 2016: -398×FY 2017: -86.9×FY 2018: -70.4×FY 2019: -74.4×FY 2020: -118×FY 2021: -257×FY 2022: -217×FY 2023: -483×FY 2024: -727×FY 2025: -281×
FY 2016 5y median -281× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.2%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -0.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31